Page 169 - 南京医科大学自然版
P. 169

第45卷第12期                印芷睿,崔 畅. 扩张型心肌病性别差异的机制与精准治疗研究进展[J].
                 2025年12月                    南京医科大学学报(自然科学版),2025,45(12):1845-1852                      ·1851 ·


               [参考文献]                                                  son of X⁃chromosome inactivation in Duchenne muscle/
                                                                       myocardium⁃manifesting carriers,non⁃manifesting carriers
               [1] TSAO C W,ADAY A W,ALMARZOOQ Z I,et al. Heart
                                                                       and related daughters[J]. Clin Genet,2013,84(3):265-
                    disease and stroke statistics⁃ 2022 update:a report from
                                                                       270
                    the American heart association[J]. Circulation,2022,145
                                                                 [15] TROGISCH F A,ABOUISSA A,KELES M,et al. Endo⁃
                    (8):e153-e639
                                                                       thelial cells drive organ fibrosis in mice by inducing
               [2] SCHULTHEISS H P,FAIRWEATHER D,CAFORIO A L
                                                                       expression of the transcription factor SOX9[J]. Sci
                    P,et al. Dilated cardiomyopathy[J]. Nat Rev Dis Primers,
                                                                       Transl Med,2024,16(736):eabq4581
                    2019,5:32
                                                                 [16]LIU C F,NI Y,THACHIL V,et al. Differential expression
               [3] ARGIRÒ A,HO C,DAY S M,et al. Sex⁃related differences
                                                                       of members of SOX family of transcription factors in
                    in genetic cardiomyopathies[J]. J Am Heart Assoc,2022,
                                                                       failing human hearts[J]. Transl Res,2022,242:66-78
                    11(9):e024947
                                                                 [17]LIU Y F,JIANG B,CAO Y D,et al. High expression levels
               [4] CODD M B,SUGRUE D D,GERSH B J,et al. Epidemiology
                                                                       and localization of Sox5 in dilated cardiomyopathy[J].
                    of idiopathic dilated and hypertrophic cardiomyopathy:a
                                                                       Mol Med Rep,2020,22(2):948-956
                    population ⁃ based study in Olmsted County,Minnesota,
                                                                 [18] VISSING C R,RASMUSSEN T B,DYBRO A M,et al.
                    1975-1984[J]. Circulation,1989,80(3):564-572
                                                                       Dilated cardiomyopathy caused by truncating titin variants:
               [5] BERGAN N,PRACHEE I,CURRAN L,et al. Systematic
                                                                       long ⁃ term outcomes,arrhythmias,response to treatment
                    review,meta⁃analysis,and population study to determine
                                                                       and sex differences[J]. J Med Genet,2021,58(12):
                    the biologic sex ratio in dilated cardiomyopathy[J]. Circu⁃
                                                                       832-841
                    lation,2025,151(7):442-459
                                                                 [19]HEY T M,RASMUSSEN T B,MADSEN T,et al. Pathogenic
               [6] LONG C Y,LIU X,XIONG Q M,et al. Sex differences in
                                                                       RBM20 ⁃ variants are associated with a severe disease
                    dilated cardiomyopathy prognosis[J]. Int Heart J,2022,
                                                                       expression in male patients with dilated cardiomyopathy[J].
                    63(1):36-42
                                                                       Circ Heart Fail,2019,12(3):e005700
               [7] MCNAMARA D M,STARLING R C,COOPER L T,et al.
                                                                 [20]VAN RIJSINGEN I A W,NANNENBERG E A,ARBUS⁃
                    Clinical and demographic predictors of outcomes in recent
                                                                       TINI E,et al. Gender⁃specific differences in major cardiac
                    onset dilated cardiomyopathy:results of the IMAC(Inter⁃
                                                                       events and mortality in lamin A/C mutation carriers[J].
                    vention in Myocarditis and Acute Cardiomyopathy)⁃ 2
                                                                       Eur J Heart Fail,2013,15(4):376-384
                    study[J]. J Am Coll Cardiol,2011,58(11):1112-1118
               [8] YOKOUCHI⁃KONISHI T,KAMIYA C A,SHIONOIRI T,    [21]WOLF C M,WANG L B,ALCALAI R,et al. Lamin A/C
                                                                       haploinsufficiency causes dilated cardiomyopathy and
                    et al. Pregnancy outcomes in women with dilated cardio⁃
                                                                       apoptosis⁃triggered cardiac conduction system disease[J].
                    myopathy:peripartum cardiovascular events predict post
                                                                       J Mol Cell Cardiol,2008,44(2):293-303
                    delivery prognosis[J]. J Cardiol,2021,77(3):217-223
                                                                 [22] PEI H,WANG W,ZHAO D,et al. G protein⁃coupled
               [9] BANGI E F,MAIKAWA N,KAUR A,et al. Pregnancy in
                    women with dilated cardiomyopathy[J]. Future Cardiol,  estrogen receptor 1 inhibits angiotensin II⁃induced cardio⁃
                    2022,18(8):661-667                                 myocyte hypertrophy via the regulation of PI3K⁃Akt⁃mTOR
                                                                       signalling and autophagy[J]. Int J Biol Sci,2019,15(1):
               [10]HERSHBERGER R E,COWAN J,JORDAN E,et al. The
                    complex and diverse genetic architecture of dilated cardio⁃  81-92
                    myopathy[J]. Circ Res,2021,128(10):1514-1532  [23]WANG M J,WANG Y,WEIL B,et al. Estrogen receptor
               [11] KAYVANPOUR E,SEDAGHAT ⁃ HAMEDANI F,AMR             beta mediates increased activation of PI3K/Akt signaling
                     A,et al. Genotype ⁃ phenotype associations in dilated  and improved myocardial function in female hearts follow⁃
                     cardiomyopathy:meta⁃analysis on more than 8000 indi⁃  ing acute ischemia[J]. Am J Physiol Regul Integr Comp
                     viduals[J]. Clin Res Cardiol,2017,106(2):127-139  Physiol,2009,296(4):R972-R978
               [12]KELLERMAYER D,SMITH J E 3rd,GRANZIER H. Titin  [24] YU H P,HSIEH Y C,SUZUKI T,et al. The PI3K/Akt
                    mutations and muscle disease[J]. Pflugers Arch,2019,  pathway mediates the nongenomic cardioprotective effects
                    471(5):673-682                                     of estrogen following trauma⁃hemorrhage[J]. Ann Surg,
               [13]FLORCZYK⁃SOLUCH U,POLAK K,DULAK J. The mul⁃         2007,245(6):971-977
                    tifaceted view of heart problem in Duchenne muscular  [25]IORGA A,CUNNINGHAM C M,MOAZENI S,et al. The
                    dystrophy[J]. Cell Mol Life Sci,2021,78(14):5447-5468  protective role of estrogen and estrogen receptors in
               [14] VIGGIANO E,PICILLO E,CIRILLO A,et al. Compari⁃     cardiovascular disease and the controversial use of estro⁃
   164   165   166   167   168   169   170   171   172   173   174